Dr. Schlueter draws on his 10-year career as a biology research scientist to counsel clients on a wide range of intellectual property issues, including patent prosecution and portfolio management, patent clearance and landscape analysis, IP due diligence, patent validity and infringement opinions, and IP licensing. His diverse technical expertise has enabled him to address IP issues in all major areas of biotechnology, including immunology and immunotherapy, biologics/biosimilars, medical diagnostics, medical devices, biosensing systems, transgenic plant and animal technology, and agricultural chemicals and products. Dr. Schlueter particularly enjoys working with his clients to identify and overcome complex IP issues that stand in the way of economic and scientific progress.
Associate IP Attorney, Casimir Jones S.C., 2018-present
Associate IP Attorney, Michael Best & Friedrich LLP, 2017-2018
Associate IP Attorney, Faegre Baker Daniels LLP, 2014-2016
Associate IP Attorney/Law Clerk, Patterson Thuente Pedersen, P.A., 2012-2014
Law Clerk, Fish & Richardson, P.C., 2011
Mitchell Hamline School of Law, 2010-2013
Post-doctoral Fellow in Chemical Biology, Harvard Medical School/MGH, 2007-2010
University of Michigan, Ph.D., Cellular, Molecular & Developmental Biology, 2001-2006
Loras College, B.S. Biology Research/English Literature, 1995-1999
State Bar of Wisconsin, 2017
State Bar of Colorado, 2014
State Bar of Minnesota, 2013
United States Patent and Trademark Office, 2010
Schlueter, P. J. and Peterson, R. T. Systematizing serendipity for cardiovascular drug
discovery. Circulation. 2009 July; 120: 255-263.
Schlueter, P. J., Peng, G., Westerfield, M., Duan, C. Insulin-like growth factor signaling
regulates zebrafish embryonic growth and development by promoting cell survival and cell
cycle progression. Cell Death and Differentiation. 2007 Jun; 14(6): 1095-105.
Schlueter, P. J., Sang, X., Duan, C., Wood, A. W. Insulin-like growth factor receptor 1b is required for zebrafish primordial germ cell migration and survival. Developmental Biology.
2007 May; 305(1): 377-87.
Schlueter, P. J., Royer, T., Farah, M. H., Laser, B., Chan, S. J., Steiner, D. F., Duan, C. Gene
duplication and functional divergence of the zebrafish insulin-like growth factor 1 receptors.
FASEB Journal. 2006 Jun; 20(8): 1230-2.
Wood, A. W., Schlueter, P. J., Duan, C. Targeted knockdown of insulin-like growth factor
binding protein-2 disrupts cardiovascular development in zebrafish embryos. Molecular
Endocrinology. 2005 Apr; 19(4): 1024-34.
Brian Lefort, Leslie Prill, and Peter Schlueter. Innovation is on the rise. Boulderopolis Magazine. 2015 January.
U.S. Patent No. 9,538,734 entitled, “Novel germ cell ablation compounds and uses thereof.”
Schlueter, P. J. (2008). Invited speaker for the Reproductive Endocrine Unit, Massachusetts
General Hospital, William F. Crowley lab. Talk entitled, “Zebrafish as a model for human
Schlueter, P. J. (2008). Invited speaker for the Vincent Center for Reproductive Biology,
Massachusetts General Hospital, Jonathan L. Tilly lab. Talk entitled, “Chemical biology in the zebrafish: phenotype-based screening for small molecule modifiers of primordial germ cell development.”
Schlueter, P. J., Duan, C. (2006). Overlapping and distinct functions of the duplicated zebrafish insulin-like growth factor 1 receptor (IGF1R) genes in early development.” Society for Integrative and Comparative Biology (SICB). Orlando,FL.
Schlueter, P. J., Chan, S. J., Steiner, D. F., Duan, C. (2005). “Functional analysis of two zebrafish insulin-like growth factor 1 receptor (IGF1R) genes in early development.” Endocrinology Meeting: Pathways to discovery and practice. San Diego, CA.
Peter J. Schlueter, Jeffrey D. Peterson (August 2017). Co-presented complimentary live
webinar entitle, “Best Practices for NDA’s and MTA’s in Collaborative Transactions.”
Peter J. Schlueter, Brian D. Lefort and Lee M. Tumminello (February, 2016). Co-presented seminar for Medical Alley Association for an R&D Workshop Series entitled, “Intellectual Property and FDA Considerations for Biotechnology and Medical Device Projects.” Golden
Peter J. Schlueter, Brian D. Lefort and Jason W. Sapsin (October, 2015). Co-presented
seminar for Colorado BioScience Association for an R&D Workshop Series entitled, “Intellectual Property and FDA Considerations for Biotechnology and Medical Device Projects.” Boulder, CO.
Peter J. Schlueter, Brian D. Lefort and Victor P. Jonas (March, 2015). Co-presented seminar for LifeScience Alley Product R&D Series entitled, “Intellectual Property Portfolio Management Strategies for Product Development.” Hamline University, St. Louis Park, MN.
University of Michigan, Graduate Student Research Assistant:
Animal Physiology Lab
Cancer Biology Lecture
Cell Biology Lecture
Woods Hole Oceanographic Institute, Teaching Assistant
Zebrafish Development and Genetics Lecture
Member, Board of Directors, ReSpectacle, Inc., 2012-present
Category 4 road cyclist, 2010-present